Learning versus confirming in clinical drug development

被引：403

作者：

Sheiner, LB

机构：

[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT LAB MED,SAN FRANCISCO,CA 94143

[2] UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARM,SAN FRANCISCO,CA 94143

[3] UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT MED,SAN FRANCISCO,CA 94143

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1997年 / 61卷 / 03期

关键词：

D O I：

10.1016/S0009-9236(97)90160-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：275 / 291

页数：17

共 34 条

[1]

AARONS L, 1994, EUR J CLIN PHARMACOL, V46, P389

[2]

Berry D A, 1991, J Biopharm Stat, V1, P81, DOI 10.1080/10543409108835007

[3] USE AND ABUSE OF REGRESSION [J].

BOX, GEP .

TECHNOMETRICS, 1966, 8 (04) :625-&

[4] PHARMACOLOGICALLY GUIDED PHASE-I CLINICAL-TRIALS BASED UPON PRECLINICAL DRUG DEVELOPMENT [J].

COLLINS, JM ;

GRIESHABER, CK ;

CHABNER, BA .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (16) :1321-1326

[5]

Egan T. D., 1996, Clinical Pharmacology and Therapeutics, V59, P129

[6]

FILLOON TG, 1995, STAT MED, V14, P932

[7]

Fleishaker J. C., 1996, Clinical Pharmacology and Therapeutics, V59, P168, DOI 10.1038/sj.clpt.1996.172

[8] BAYESIAN METHODS FOR PHASE-I CLINICAL-TRIALS [J].

GATSONIS, C ;

GREENHOUSE, JB .

STATISTICS IN MEDICINE, 1992, 11 (10) :1377-1389

[9]

Hecht A., 1996, Clinical Pharmacology and Therapeutics, V59, P163, DOI 10.1038/sj.clpt.1996.151

[10] THEOPHYLLINE TARGET CONCENTRATION IN SEVERE AIRWAYS OBSTRUCTION - 10 OR 20 MG/L - A RANDOMIZED CONCENTRATION-CONTROLLED TRIAL [J].

HOLFORD, N ;

BLACK, P ;

COUCH, R ;

KENNEDY, J ;

BRIANT, R .

CLINICAL PHARMACOKINETICS, 1993, 25 (06) :495-505

← 1 2 3 4 →